发明名称 BIOMARKERS FOR CERVICAL CANCER
摘要 The present invention relates to biomarkers for chemoradioresistant subtypes of cervical cancer. In particular the present invention relates to a method for predicting a predisposition to a chemoradioresistant cervical cancer in a subject, a method for diagnosing a chemoradioresistant cervical cancer in a subject, a method for predicting the likelihood of recurrence of cervical cancer in a cervical cancer patient under treatment, and a method for predicting the prognosis for a patient with a chemoradioresistant cervical cancer.
申请公布号 US2016046997(A1) 申请公布日期 2016.02.18
申请号 US201314436680 申请日期 2013.10.17
申请人 Oslo universitetssykehus HF 发明人 Lyng Heidi;Lando Malin
分类号 C12Q1/68;G01N33/574 主分类号 C12Q1/68
代理机构 代理人
主权项 1. A kit for detecting loss of gene expression associated with cervical cancer, consisting essentially of: a) a first gene expression informative reagent for identification of loss or decrease of gene expression of a first gene located at the chromosomal region 3p11.2-p14.2; and b) a second gene expression informative reagent for identification of loss or decrease of gene expression of a second gene located at the chromosomal region 3p11.2-p14.2.
地址 Oslo NO